Regulatory & Legal

A new initiative promises to pay farmers for regenerative practices while offering corporations verifiable climate assets. Can it fix the troubled carbon market?

As giant brokers merge, a global network of specialists doubles down on expertise, adding a UK firm to tackle complex risks in aerospace and life science.

A new report reveals a 67% surge in mobile fraud, with sophisticated malware targeting over 1,200 banking apps to drain accounts directly from your phone.

A leading firearms maker partners with the National Forest Foundation, linking special edition rifle sales to reforestation and wildlife restoration projects.

LGM Pharma is investing $15 million to expand its Texas and Colorado sites, boosting domestic production of specialized drugs and fortifying the U.S. supply chain.

AI firm Corvex goes public via a merger with Movano, raising $40.2M to challenge cloud giants with its high-security GPU infrastructure platform.

Quebec’s new budget maintains support for its vital life sciences sector, but industry leaders warn new tax rules could hinder innovation for small firms.

A new startup from security veterans says it can stop data theft before it happens by moving threat detection from the cloud directly onto the endpoint.

A new report reveals how smarter energy use could slash US power bills by tapping into the grid's hidden capacity, with tech giants like Google leading the push.

A new report reveals a huge compliance gap as companies hire globally for AI talent, exposing them to massive legal and financial risks.

An upcoming webinar aims to move beyond polarized debates, exploring the future of scientific testing as public support wanes and new technologies emerge.

A new $7 million deal will use a digital marketplace to deliver 16 million doses of a life-saving antibiotic to children in Burkina Faso. But can it work?

New analysis shows a summer of sporting glory in 2026 could see Brits open their wallets, injecting up to £400 million into the UK economy.

A landmark study reveals GLP-1 drugs like Ozempic dramatically reduce risks of depression and anxiety, hinting at a new era for mental healthcare.

As costs soar, Angle Health's new webinar series brings in top experts to offer brokers and employers actionable strategies on everything from pharmacy spend to AI.

Following positive study results, BioPorto is moving its NGAL test for adult acute kidney injury toward FDA review, aiming to revolutionize early detection.

A new DoD-funded trial combines a biologic drug with a plant-based supplement, aiming to break treatment barriers for ulcerative colitis, a major military issue.

A Texas basketball academy's championship win, led by NBA vet Jermaine O'Neal, spotlights a radical new model: a two-hour school day for elite athletes.

International Schooling achieves prestigious NEASC accreditation, validating its model for 15,000+ students and signaling a new era for online education.

The 'Beauty in Black' star, whose character has prostate cancer, is now a Global Ambassador for ZERO, tackling the disease's deadly toll on Black men.